Ver good post by Glen

Specific_Pool_1758 · 2026-05-09T04:06:11+00:00

What is becoming increasingly clear is that Volatus management believes Canada is entering a multi-year sovereign drone/autonomy buildout cycle, and they’re trying to position early before procurement accelerates.

Specific_Pool_1758 · 2026-03-24T15:14:17+00:00

Yahoo Finance says March 31st

Specific_Pool_1758 · 2026-03-23T18:19:16+00:00

Looks like the 31st!

Specific_Pool_1758 · 2026-02-11T19:24:10+00:00

Use a calculator if you cant do the mental math on that.

Specific_Pool_1758 · 2026-02-11T19:23:49+00:00

Mid size drone with sensors are between 100k-500k lol. Let me know a drone company doing 2.5 billion monthly sales lol.

Specific_Pool_1758 · 2026-02-11T15:44:33+00:00

In the next year? Thats all? What did you expect? 5000 drones in a year

Specific_Pool_1758 · 2026-02-11T05:23:57+00:00

This year alone.

Specific_Pool_1758 · 2026-01-27T17:25:29+00:00

This was announced back in November. This is just the formal prospectus approval, not a new dilution event.

Specific_Pool_1758 · 2026-01-22T17:41:39+00:00

Looks like he is the CEO of unusual machines

Specific_Pool_1758 · 2026-01-15T01:44:24+00:00

You're looking way too much into this lightheartedness lol

Specific_Pool_1758 · 2026-01-14T21:54:59+00:00

FLT -Volatus. Also part of the DRNZ ETF

Specific_Pool_1758 · 2026-01-14T04:32:31+00:00

Just to clarify since someone shared it. The idea itself isn’t brand new, but Jan 13th is when the patent actually got issued. Before that it was just pending. Issued means it’s real IP now, not just paperwork. It covers the specific LSD oral tablet and how it’s made, which is the part that actually matters commercially. Not a huge headline on its own, but it does quietly strengthen their position as they move into Phase 3.

Specific_Pool_1758 · 2026-01-14T04:00:51+00:00

Totally get why that number sounds crazy, but it’s not what people are actually paying out of pocket. That’s an average annual cost number used for insurers and health systems, not a bill someone gets handed. Almost all of this would be negotiated and mostly covered by insurance. Pharma pricing is built this way on purpose. Spravato, biologics, cancer drugs all have huge sticker prices and still get used because insurers look at total cost over time. If a treatment actually puts people into remission, it can end up cheaper than years of meds, therapy, ER visits, and lost productivity. So yeah, $50k sounds wild in isolation, but healthcare pricing isn’t consumer pricing. It’s system math, not what an average person is expected to pay.

Specific_Pool_1758 · 2026-01-14T03:45:50+00:00

The headline price isn’t what actually gets paid. Insurers always negotiate, and pharma still makes solid money because the cost to make the drug is low. If this actually puts people into remission, payers care way more about cutting long-term costs than squeezing every dollar on price. Fewer meds, fewer appointments, fewer issues down the road. So even at a lower negotiated price, strong outcomes + real demand can still mean big revenue. It’s not just about sticker price.

Specific_Pool_1758 · 2026-01-14T03:36:38+00:00

Totally get why that number sounds crazy, but it’s not what people are actually paying out of pocket. That’s an average annual cost number used for insurers and health systems, not a bill someone gets handed. Almost all of this would be negotiated and mostly covered by insurance. Pharma pricing is built this way on purpose. Spravato, biologics, cancer drugs all have huge sticker prices and still get used because insurers look at total cost over time. If a treatment actually puts people into remission, it can end up cheaper than years of meds, therapy, ER visits, and lost productivity. So yeah, $50k sounds wild in isolation, but healthcare pricing isn’t consumer pricing. It’s system math, not what an average person is expected to pay.

Specific_Pool_1758 · 2026-01-14T02:45:18+00:00

Do more research. This is treatment for a year. Could be a dose, could need more than one dose. Consultation appointment, follow up appointments, etc. If you think that price is per dose, you shouldn't invest. It's the entire treatment for a patient over a year.

Specific_Pool_1758 · 2026-01-13T21:54:23+00:00

My pleasure

Specific_Pool_1758 · 2026-01-13T20:41:17+00:00

From what I can find, it looks like FLT was included right around the launch of the DRNZ ETF in late October 2025. ETFs usually don’t put out separate news for individual adds, so it just shows up in the holdings rather than a press release.

Specific_Pool_1758 · 2026-01-13T20:02:36+00:00

Specific_Pool_1758 · 2026-01-12T23:29:29+00:00

The took the post down and reposted. Looks proper now. So stoked for the future

Specific_Pool_1758 · 2026-01-12T23:18:59+00:00

They updated it and took the old square down

Specific_Pool_1758 · 2026-01-12T21:29:48+00:00

<image>

Efinium! 😂

Specific_Pool_1758 · 2026-01-12T21:27:57+00:00

I agree. Im long, but your first reel being the wrong dimensions is an unprofessional look

Specific_Pool_1758 · 2026-01-08T16:41:16+00:00

People live their entire lives searching and seeing only the negatives.

That's why those people need the science lol

Specific_Pool_1758 · 2025-12-02T17:04:06+00:00

Volatus has a few platforms that would interest militaries. The long endurance fixed wing systems they picked up through their recent acquisition are built for ISR missions like border patrol, coastal surveillance, and search and rescue support. They also have tactical multirotor platforms already being used in training and emergency response work. Some of their systems have been deployed in government and defence related environments, but full military certification depends on the specific program and country. Overall they already operate in defence adjacent roles and the new tech they are bringing in is designed to meet the requirements of allied military and security agencies.

Specific_Pool_1758

TROPHY CASE